Proline metabolism and cancer

被引:91
作者
Phang, James M. [1 ]
Liu, Wei [1 ]
机构
[1] NCI Frederick, Metab & Canc Susceptibil Sect, Comparat Carcinogenesis Lab, Ctr Canc Res, Frederick, MD 21702 USA
来源
FRONTIERS IN BIOSCIENCE-LANDMARK | 2012年 / 17卷
关键词
Apoptosis; Autophagy; Metabolic stress; Survival; Review; PPAR-GAMMA; MATRIX METALLOPROTEINASES; TUMOR-SUPPRESSOR; GENE-EXPRESSION; OXIDIZED LDL; OXIDASE; APOPTOSIS; GENERATION; MICRORNAS; INFLAMMATION;
D O I
10.2741/4022
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Proline plays a special role in cancer metabolism. Proline oxidase (POX), a.k.a. proline dehydrogenase (PRODH), is among a few genes induced rapidly and robustly by P53, the tumor suppressor. Ectopic expression of POX under control of tet-off promoter initiated mitochondrial apoptosis. The mechanism activated by POX is mediated by its production of ROS. In immunodeficient mice, POX overexpression markedly retarded growth of xenograft tumors. In human tumors of the digestive tract and kidney, POX was markedly decreased, suggesting that the suppressive effect of POX was downregulated. This was not due to POX gene mutations or hypermethylation. Instead, a microRNA, miR-23b*, expressed at high levels in tumors, was a potent inhibitor of POX expression. Furthermore, antagomirs of miR-23b* reversed the downregulated expression of POX and its tumor-suppressive effect, thereby providing a therapeutic strategy. POX not only responds to genotoxic stress, but also to inflammatory and metabolic stress. Depending on microenvironmental and temporal factors, POX can mediate oppositely-directed responses-programmed cell death, on the one hand, and survival, on the other.
引用
收藏
页码:1835 / 1845
页数:11
相关论文
共 64 条
[1]   REGULATION OF HUMAN DIHYDROFOLATE REDUCTASE ACTIVITY AND EXPRESSION [J].
Abali, Ernine Ercikan ;
Skacel, Nancy E. ;
Celikkaya, Hital ;
Hsieh, Yi-Ching .
FOLIC ACID AND FOLATES, 2008, 79 :267-+
[2]  
Adams E, 1970, Int Rev Connect Tissue Res, V5, P1
[3]   Metabolic profiling reveals key metabolic features of renal cell carcinoma [J].
Catchpole, Gareth ;
Platzer, Alexander ;
Weikert, Cornelia ;
Kempkensteffen, Carsten ;
Johannsen, Manfred ;
Krause, Hans ;
Jung, Klaus ;
Miller, Kurt ;
Willmitzer, Lothar ;
Selbig, Joachim ;
Weikert, Steffen .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2011, 15 (01) :109-118
[4]   Targeting Matrix Metalloproteinases in Inflammatory Conditions [J].
Clutterbuck, A. L. ;
Asplin, K. E. ;
Harris, P. ;
Allaway, D. ;
Mobasheri, A. .
CURRENT DRUG TARGETS, 2009, 10 (12) :1245-1254
[5]   Novel function for hydroxyproline oxidase in apoptosis through generation of reactive oxygen species [J].
Cooper, Sandra K. ;
Pandhare, Jui ;
Donald, Steven P. ;
Phang, James M. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (16) :10485-10492
[6]   Cancer therapy - Matrix metalloproteinase inhibitors and cancer: Trials and tribulations [J].
Coussens, LM ;
Fingleton, B ;
Matrisian, LM .
SCIENCE, 2002, 295 (5564) :2387-2392
[7]   Inflammation and cancer [J].
Coussens, LM ;
Werb, Z .
NATURE, 2002, 420 (6917) :860-867
[8]   MYC, microRNAs and glutamine addiction in cancers [J].
Dang, Chi V. .
CELL CYCLE, 2009, 8 (20) :3243-3245
[9]   Oncogenic alterations of metabolism [J].
Dang, CV ;
Semenza, GL .
TRENDS IN BIOCHEMICAL SCIENCES, 1999, 24 (02) :68-72
[10]  
De Ingeniis J, FUNCTIONAL RED UNPUB